BACKGROUND Tuberculosis is primarily a pulmonary disease, but it can affect almost any organ system, with lymph node involvement being the most common form of extrapulmonary tuberculosis and tuberculous pleuritis being the 2 nd most frequent extrapulmonary manifestation. Immune-compromising diseases such as HIV, have resulted in increase in the incidence of tuberculous lymphadenitis. METHODS This study is a prospective study, which included 80 patients, in the age group of 15-60 years, done over a period of 18 months from November 2016 to April 2018 in Upgraded Department of Pathology, Osmania General Hospital, Hyderabad, a tertiary referral centre for the state of Telangana and various districts of neighbouring states. In the present study, patients who presented with cervical lymphadenopathy as the manifestation of extrapulmonary tuberculosis were included. Cervical lymphadenopathy is the most common presentation of EPTB. Pus from the suspected lymph nodes was aspirated for cytological examination, ZN staining and GeneXpert analysis. Biopsy from the suspected lymph node was obtained and the material processed for CBNAAT, histopathology, Ziehl Neelsen staining and IHC. RESULTS CBNAAT was positive in 70 (87.5%) cases on cytological aspirates with 24 (30%) cases showing rifampicin resistance and on biopsy, 64/80 (80%) cases were positive on CBNAAT with rifampicin resistance in 25 (31.25%) cases. IHC with anti-MPT64 antibody was positive in 72 (90%) cases with sensitivity, specificity, positive and negative predictive value of 100%, 97%, 98% and 100% respectively and p value of <0.0001. CONCLUSIONS Present study provides the insight for the feasibility of using CBNAAT and IHC as diagnostic techniques for better management of EPTB patients and be useful in settings where culture or higher molecular facilities are not available.